YU49496B - 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals - Google Patents
2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticalsInfo
- Publication number
- YU49496B YU49496B YU42395A YU42395A YU49496B YU 49496 B YU49496 B YU 49496B YU 42395 A YU42395 A YU 42395A YU 42395 A YU42395 A YU 42395A YU 49496 B YU49496 B YU 49496B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- nervous system
- central nervous
- salts
- disulfophenyl
- pharmaceuticals
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Opisan jc 2.4-disulfo a-fenil-tert-butil nitron i njegove farmaceutski prihvatljive soli. Ovi su materijali korisni kao farmaceutska sredstva za oralno ili perenteralno, na primer intravensko, davanje pacijentima koji pate od akutne oksidacije centralnog nervnog sistema, sto se javlja kod mozdanog udara, ili od postepene oksidacije centralnog nervnog sistema, koja se moze iskazati kao progresivni gubitak funkcije centralnog nervnog sistema. Materijali se takode mogu koristiti za ublazavanje nezeljenog delovanja lekova za kancerozna oboljenja koji izazivaju oksidaciona ostecenja.Prijava sadrži još 1 nezavisan i 1 zavisan patentni zahtev2.4-Disulfo [alpha] -phenyl-tert-butyl nitron and its pharmaceutically acceptable salts are described. These materials are useful as pharmaceutical agents for oral or perenteral, for example, intravenous, administration to patients suffering from acute oxidation of the central nervous system, occurring in stroke, or from gradual oxidation of the central nervous system, which may be manifested as progressive loss of function of the central nervous system. The materials can also be used to alleviate the undesirable effects of cancerous drugs that cause oxidative damage. The application contains 1 more independent and 1 dependent claim
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU42395A YU49496B (en) | 1995-06-21 | 1995-06-21 | 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU42395A YU49496B (en) | 1995-06-21 | 1995-06-21 | 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
YU42395A YU42395A (en) | 1998-08-14 |
YU49496B true YU49496B (en) | 2006-08-17 |
Family
ID=47598467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU42395A YU49496B (en) | 1995-06-21 | 1995-06-21 | 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals |
Country Status (1)
Country | Link |
---|---|
YU (1) | YU49496B (en) |
-
1995
- 1995-06-21 YU YU42395A patent/YU49496B/en unknown
Also Published As
Publication number | Publication date |
---|---|
YU42395A (en) | 1998-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9204268A (en) | A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME. | |
KR870005637A (en) | Drug depot | |
FI962589A0 (en) | 2,4-Disulfophenylbutylnitrone, its salts and their use as pharmaceuticals | |
ES2157307T3 (en) | TOPICAL COMPOSITION CONTAINING A SUBSTANCE ANTAGONIST P. | |
ME00416B (en) | Celecoxib compositions | |
ES2161288T3 (en) | COMPRESSED CLOSED WITH POLYMER THAT INCLUDES AMOXYCLINE AND CLAVULANATE. | |
CL2004001191A1 (en) | COMPOUNDS DERIVED FROM STEROIDS 17 ALPHA-FLUORO RENTED, WITH ANTIGESTAGENA ACTIVITY; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE OF THE COMPOUND IN THE PREPARATION OF AN ANTIESTROGENIC MEDICINAL PRODUCT, FOR THE TREATMENT OF DISMENORREA | |
ES2116447T3 (en) | A PHARMACEUTICAL COMPOSITION CONTAINING A DEFINED LIPID SYSTEM. | |
TW355683B (en) | Composition containing micronized nebivolol | |
ATE270544T1 (en) | SEMI-SOLID MEDICINAL PREPARATION CONTAINING ISOTRETINOIN | |
NZ501950A (en) | Medicinal compositions for application to mucosa | |
UA29469C2 (en) | Liposomal pharmaceutical compositions for intravenous administration | |
BR0007294A (en) | Improved pharmaceutical formulations | |
DE69923336D1 (en) | ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED | |
RS49599B (en) | Use of h+, k+ -atpaze inhibitors and glucocortifoids and pharmaceutical formulation | |
NL193820B (en) | Solid pharmaceutical dosage form for oral administration of Ibuprofen. | |
AR011437A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT. | |
YU49496B (en) | 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals | |
MA26788A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THEIR PREPARATION | |
DE69626401D1 (en) | MEDICINAL PRODUCTS FOR TOPICAL USE | |
PT1144420E (en) | PHOSPHATIDILINOSITOIS SULPHATATED TO ITS PREPARATION AND ITS UTILIZATION | |
TR199901237T2 (en) | A new therapeutic application of a thienylcyclohexylamine derivative. | |
ES2128353T3 (en) | TOPIC COMPOSITION CONTAINING PENCICLOVIR. | |
ES2188670T3 (en) | FORMULATIONS CONTAINING CODEINA. | |
ATE227984T1 (en) | AGENTS AGAINST MALARIA AND BABESIA AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |